Actinium Pharmaceuticals, Inc. 8-K/A

What Happened

• Actinium Pharmaceuticals, Inc. (NASDAQ: ATNM) filed a Form 8‑K on March 26, 2026 (Accession No. 0001213900-26-034807) reporting the results of matters submitted to a vote of its security holders under Item 5.07.
• The filing discloses the submission and outcome of security‑holder votes and states that no other changes were made to the Original Form 8‑K.

Key Details

• Filing date: March 26, 2026.
• Reported under Item 5.07: Submission of Matters to a Vote of Security Holders.
• SEC Accession Number: 0001213900-26-034807.
• The filing indicates no other amendments or changes to the Original Form 8‑K beyond the vote disclosure.

Why It Matters

• Vote results affect corporate governance matters (such as director elections or shareholder proposals) that can influence company direction and oversight.
• This disclosure gives investors official, SEC‑filed confirmation of how Actinium’s shareholders voted on matters presented at the meeting; review the full filing for the specific proposals and vote tallies.